|
Volumn 19, Issue 6, 2000, Pages 463-471
|
Removal of amphipathic epitopes from genetically engineered antibodies: Production of modified immunoglobulins with reduced immunogenicity
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHIMERIC ANTIBODY;
EPIDERMAL GROWTH FACTOR RECEPTOR;
EPITOPE;
IMMUNOGLOBULIN;
PEPTIDE;
R3 ANTIBODY;
UNCLASSIFIED DRUG;
AMINO ACID SEQUENCE;
ANTIBODY AFFINITY;
ANTIGEN RECOGNITION;
ARTICLE;
COMPUTER PROGRAM;
DATA BASE;
GENETIC ENGINEERING;
HUMAN;
IMMUNE RESPONSE;
IMMUNOGENICITY;
LYMPHOCYTE;
MONKEY;
MOUSE;
NONHUMAN;
NUCLEOTIDE SEQUENCE;
PRIORITY JOURNAL;
PROTEIN DOMAIN;
SEQUENCE ANALYSIS;
SEQUENCE HOMOLOGY;
SITE DIRECTED MUTAGENESIS;
ALGORITHMS;
ANIMALS;
ANTIBODIES;
ANTIBODY SPECIFICITY;
CERCOPITHECUS AETHIOPS;
COMPLEMENTARITY DETERMINING REGIONS;
EPITOPES;
HUMANS;
IMMUNIZATION;
MICE;
MOLECULAR SEQUENCE DATA;
PROTEIN ENGINEERING;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
RECOMBINANT FUSION PROTEINS;
SEQUENCE HOMOLOGY, AMINO ACID;
MURINAE;
|
EID: 0034532441
PISSN: 0272457X
EISSN: None
Source Type: Journal
DOI: 10.1089/027245700750053959 Document Type: Article |
Times cited : (38)
|
References (34)
|